_id
69105ae9ccc777a4e85d57c9
Ticker
DHR
Name
Danaher Corporation
Exchange
NYSE
Address
2200 Pennsylvania Avenue N.W., Washington, DC, United States, 20037-1701
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://www.danaher.com
Description
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.
Last Close
232.37
Volume
1461346
Current Price
226.33
Change
-2.599302835994316
Last Updated
2025-11-29T12:14:33.273Z
Image
-
Ipo Date
1979-01-05T00:00:00.000Z
Market Cap
162386182144
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.98691875
Sentiment Sources
32
Rating
4.6154
Target Price
254.2
Strong Buy
19
Buy
4
Hold
3
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
6053000000
Cost Of Revenue
2530000000
Gross Profit
3523000000
Operating Expenses
2369000000
Operating Income
1154000000
Interest Expense
67000000
Pretax Income
1076000000
Net Income
908000000
Eps
1.2722432394563543
Dividends Per Share
229000000
Shares Outstanding
706349563
Income Tax Expense
168000000
EBITDA
1765000000
Operating Margin
19.064926482735835
Total Other Income Expense Net
-78000000
Cash
1528000000
Short Term Investments
-
Receivables
3755000000
Inventories
2674000000
Total Current Assets
9606000000
Property Plant Equipment
5376000000
Total Assets
79897000000
Payables
1698000000
Short Term Debt
23000000
Long Term Debt
16833000000
Total Liabilities
28826000000
Equity
51071000000
Depreciation
723000000
Change In Working Capital
-67000000
Cash From Operations
1662000000
Capital Expenditures
292000000
Cash From Investing
-312000000
Cash From Financing
-2724000000
Net Change In Cash
-782000000
PE
46.7588
PB
3.162885414423058
ROE
1.7779170174854615
ROA
1.1364631963653204
FCF
1370000000
Fcf Percent
0.22633404923178588
Piotroski FScore
4
Health Score
63
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
3.5
Economic Moat Investing Score
8.3
Garp Investing Score
6
Growth Investing Score
5
Momentum Investing Score
6
Net Net Investing Score
2.5
Quality Investing Score
7
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
6053000000
Quarters > 0 > income Statement > cost Of Revenue
2530000000
Quarters > 0 > income Statement > gross Profit
3523000000
Quarters > 0 > income Statement > operating Expenses
2369000000
Quarters > 0 > income Statement > operating Income
1154000000
Quarters > 0 > income Statement > interest Expense
67000000
Quarters > 0 > income Statement > pretax Income
1076000000
Quarters > 0 > income Statement > net Income
908000000
Quarters > 0 > income Statement > eps
1.2722432394563543
Quarters > 0 > income Statement > dividends Per Share
229000000
Quarters > 0 > income Statement > shares Outstanding
713700000
Quarters > 0 > income Statement > income Tax Expense
168000000
Quarters > 0 > income Statement > EBITDA
1765000000
Quarters > 0 > income Statement > operating Margin
19.064926482735835
Quarters > 0 > income Statement > total Other Income Expense Net
-78000000
Quarters > 0 > balance Sheet > cash
1528000000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
3755000000
Quarters > 0 > balance Sheet > inventories
2674000000
Quarters > 0 > balance Sheet > total Current Assets
9606000000
Quarters > 0 > balance Sheet > property Plant Equipment
5376000000
Quarters > 0 > balance Sheet > total Assets
79897000000
Quarters > 0 > balance Sheet > payables
1698000000
Quarters > 0 > balance Sheet > short Term Debt
23000000
Quarters > 0 > balance Sheet > long Term Debt
16833000000
Quarters > 0 > balance Sheet > total Liabilities
28826000000
Quarters > 0 > balance Sheet > equity
51071000000
Quarters > 0 > cash Flow > net Income
908000000
Quarters > 0 > cash Flow > depreciation
723000000
Quarters > 0 > cash Flow > change In Working Capital
-67000000
Quarters > 0 > cash Flow > cash From Operations
1662000000
Quarters > 0 > cash Flow > capital Expenditures
292000000
Quarters > 0 > cash Flow > cash From Investing
-312000000
Quarters > 0 > cash Flow > cash From Financing
-2724000000
Quarters > 0 > cash Flow > net Change In Cash
-782000000
Quarters > 0 > ratios > PE
1.2722432394563543
Quarters > 0 > ratios > PB
3.162885414423058
Quarters > 0 > ratios > ROE
1.7779170174854615
Quarters > 0 > ratios > ROA
1.1364631963653204
Quarters > 0 > ratios > FCF
1370000000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.22633404923178588
Quarters > 0 > health Score
63
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
5936000000
Quarters > 1 > income Statement > cost Of Revenue
1981000000
Quarters > 1 > income Statement > gross Profit
3955000000
Quarters > 1 > income Statement > operating Expenses
2763000000
Quarters > 1 > income Statement > operating Income
1192000000
Quarters > 1 > income Statement > interest Expense
71000000
Quarters > 1 > income Statement > pretax Income
655000000
Quarters > 1 > income Statement > net Income
555000000
Quarters > 1 > income Statement > eps
0.7717980809345014
Quarters > 1 > income Statement > dividends Per Share
229000000
Quarters > 1 > income Statement > shares Outstanding
719100000
Quarters > 1 > income Statement > income Tax Expense
100000000
Quarters > 1 > income Statement > EBITDA
1337000000
Quarters > 1 > income Statement > operating Margin
20.080862533692724
Quarters > 1 > income Statement > total Other Income Expense Net
-537000000
Quarters > 1 > balance Sheet > cash
2957000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
4516000000
Quarters > 1 > balance Sheet > inventories
2689000000
Quarters > 1 > balance Sheet > total Current Assets
10999000000
Quarters > 1 > balance Sheet > property Plant Equipment
6409000000
Quarters > 1 > balance Sheet > total Assets
81620000000
Quarters > 1 > balance Sheet > payables
1725000000
Quarters > 1 > balance Sheet > short Term Debt
1702000000
Quarters > 1 > balance Sheet > long Term Debt
16853000000
Quarters > 1 > balance Sheet > total Liabilities
29278000000
Quarters > 1 > balance Sheet > equity
52334000000
Quarters > 1 > cash Flow > net Income
555000000
Quarters > 1 > cash Flow > depreciation
611000000
Quarters > 1 > cash Flow > change In Working Capital
-395000000
Quarters > 1 > cash Flow > cash From Operations
1338000000
Quarters > 1 > cash Flow > capital Expenditures
248000000
Quarters > 1 > cash Flow > cash From Investing
-258000000
Quarters > 1 > cash Flow > cash From Financing
-247000000
Quarters > 1 > cash Flow > net Change In Cash
964000000
Quarters > 1 > ratios > PE
0.7717980809345014
Quarters > 1 > ratios > PB
3.1099075744258036
Quarters > 1 > ratios > ROE
1.060496044636374
Quarters > 1 > ratios > ROA
0.679980396961529
Quarters > 1 > ratios > FCF
1090000000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.18362533692722371
Quarters > 1 > health Score
60
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
5741000000
Quarters > 2 > income Statement > cost Of Revenue
2215000000
Quarters > 2 > income Statement > gross Profit
3526000000
Quarters > 2 > income Statement > operating Expenses
2237000000
Quarters > 2 > income Statement > operating Income
1289000000
Quarters > 2 > income Statement > interest Expense
72000000
Quarters > 2 > income Statement > pretax Income
1129000000
Quarters > 2 > income Statement > net Income
954000000
Quarters > 2 > income Statement > eps
1.3235294117647058
Quarters > 2 > income Statement > dividends Per Share
194000000
Quarters > 2 > income Statement > shares Outstanding
720800000
Quarters > 2 > income Statement > income Tax Expense
175000000
Quarters > 2 > income Statement > EBITDA
1792000000
Quarters > 2 > income Statement > operating Margin
22.45253440167218
Quarters > 2 > income Statement > total Other Income Expense Net
-160000000
Quarters > 2 > balance Sheet > cash
1993000000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
4314000000
Quarters > 2 > balance Sheet > inventories
2532000000
Quarters > 2 > balance Sheet > total Current Assets
9525000000
Quarters > 2 > balance Sheet > property Plant Equipment
6210000000
Quarters > 2 > balance Sheet > total Assets
79116000000
Quarters > 2 > balance Sheet > payables
1722000000
Quarters > 2 > balance Sheet > short Term Debt
1601000000
Quarters > 2 > balance Sheet > long Term Debt
15976000000
Quarters > 2 > balance Sheet > total Liabilities
28259000000
Quarters > 2 > balance Sheet > equity
50849000000
Quarters > 2 > cash Flow > net Income
954000000
Quarters > 2 > cash Flow > depreciation
591000000
Quarters > 2 > cash Flow > change In Working Capital
-403000000
Quarters > 2 > cash Flow > cash From Operations
1299000000
Quarters > 2 > cash Flow > capital Expenditures
245000000
Quarters > 2 > cash Flow > cash From Investing
-242000000
Quarters > 2 > cash Flow > cash From Financing
-1255000000
Quarters > 2 > cash Flow > net Change In Cash
-85000000
Quarters > 2 > ratios > PE
1.3235294117647058
Quarters > 2 > ratios > PB
3.2082964070089877
Quarters > 2 > ratios > ROE
1.8761430903262604
Quarters > 2 > ratios > ROA
1.2058243591688156
Quarters > 2 > ratios > FCF
1054000000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.1835917087615398
Quarters > 2 > health Score
61
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
6538000000
Quarters > 3 > income Statement > cost Of Revenue
2648000000
Quarters > 3 > income Statement > gross Profit
3890000000
Quarters > 3 > income Statement > operating Expenses
2144000000
Quarters > 3 > income Statement > operating Income
1746000000
Quarters > 3 > income Statement > interest Expense
61000000
Quarters > 3 > income Statement > pretax Income
1315000000
Quarters > 3 > income Statement > net Income
1086000000
Quarters > 3 > income Statement > eps
1.4731416169289202
Quarters > 3 > income Statement > dividends Per Share
195000000
Quarters > 3 > income Statement > shares Outstanding
737200000
Quarters > 3 > income Statement > income Tax Expense
229000000
Quarters > 3 > income Statement > EBITDA
1971000000
Quarters > 3 > income Statement > operating Margin
26.705414499847045
Quarters > 3 > income Statement > total Other Income Expense Net
-431000000
Quarters > 3 > balance Sheet > cash
2078000000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
4390000000
Quarters > 3 > balance Sheet > inventories
2330000000
Quarters > 3 > balance Sheet > total Current Assets
9497000000
Quarters > 3 > balance Sheet > property Plant Equipment
6074000000
Quarters > 3 > balance Sheet > total Assets
77542000000
Quarters > 3 > balance Sheet > payables
1753000000
Quarters > 3 > balance Sheet > short Term Debt
678000000
Quarters > 3 > balance Sheet > long Term Debt
15500000000
Quarters > 3 > balance Sheet > total Liabilities
27992000000
Quarters > 3 > balance Sheet > equity
49543000000
Quarters > 3 > cash Flow > net Income
1086000000
Quarters > 3 > cash Flow > depreciation
595000000
Quarters > 3 > cash Flow > change In Working Capital
174000000
Quarters > 3 > cash Flow > cash From Operations
2019000000
Quarters > 3 > cash Flow > capital Expenditures
516000000
Quarters > 3 > cash Flow > cash From Investing
-694000000
Quarters > 3 > cash Flow > cash From Financing
-1692000000
Quarters > 3 > cash Flow > net Change In Cash
-549000000
Quarters > 3 > ratios > PE
1.4731416169289202
Quarters > 3 > ratios > PB
3.367791130936762
Quarters > 3 > ratios > ROE
2.19203520174394
Quarters > 3 > ratios > ROA
1.400531324959377
Quarters > 3 > ratios > FCF
1503000000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.22988681553992046
Quarters > 3 > health Score
63
Valuation > metrics > PE
46.7588
Valuation > metrics > PB
3.162885414423058
Valuation > final Score
22.26058585576942
Valuation > verdict
46.2% Overvalued
Profitability > metrics > ROE
1.7779170174854615
Profitability > metrics > ROA
9.452425567353737
Profitability > metrics > Net Margin
0.1500082603667603
Profitability > final Score
54
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.564429911299955
Risk > metrics > Interest Coverage
17.223880597014926
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
5.5816385822196395
Liquidity > metrics > Quick Ratio
4.027890761185358
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
68.90092425574197
Prev Valuations > 1
67.91703592991013
Prev Valuations > 2
66.32208869063238
Prev Profitabilities > 0
31
Prev Profitabilities > 1
59
Prev Profitabilities > 2
59
Prev Risks > 0
88
Prev Risks > 1
88
Prev Risks > 2
88
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:23:37.080Z
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADanaher Stock (DHR) News Today: BofA Lifts Price Target to $265, Wells Fargo to $240 as 2026 Normalization Comes Into Focus ts2.tech
Read more →Wells Fargo Adjusts Price Target for Danaher (DHR) to $240 | DHR Stock News GuruFocus
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$254.2
Analyst Picks
Strong Buy
19
Buy
4
Hold
3
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 59.71% of the total shares of Danaher Corporation
1.
Vanguard Group Inc(8.4868%)
since
2025/06/30
2.
BlackRock Inc(7.2947%)
since
2025/06/30
3.
State Street Corp(3.8125%)
since
2025/06/30
4.
Vanguard Total Stock Mkt Idx Inv(2.826%)
since
2025/07/31
5.
Wellington Management Company LLP(2.3848%)
since
2025/06/30
6.
T. Rowe Price Associates, Inc.(2.3205%)
since
2025/06/30
7.
Capital Research & Mgmt Co - Division 3(2.2967%)
since
2025/06/30
8.
Vanguard 500 Index Investor(2.2019%)
since
2025/07/31
9.
FMR Inc(2.0254%)
since
2025/06/30
10.
Geode Capital Management, LLC(1.9169%)
since
2025/06/30
11.
Morgan Stanley - Brokerage Accounts(1.5827%)
since
2025/06/30
12.
NORGES BANK(1.3994%)
since
2025/06/30
13.
Bank of New York Mellon Corp(1.1745%)
since
2025/06/30
14.
Fidelity 500 Index(1.1276%)
since
2025/07/31
15.
SPDR® S&P 500® ETF(1.0753%)
since
2025/08/31
16.
iShares Core S&P 500 ETF(1.0704%)
since
2025/08/31
17.
Northern Trust Corp(1.0514%)
since
2025/06/30
18.
JPMorgan Chase & Co(1.0317%)
since
2025/06/30
19.
T. Rowe Price Investment Management,Inc.(0.9711%)
since
2025/06/30
20.
Vanguard Dividend Growth Inv(0.942%)
since
2025/06/30
21.
HHG PLC(0.9115%)
since
2025/06/30
22.
UBS Asset Mgmt Americas Inc(0.8889%)
since
2025/06/30
23.
Parnassus Investments LLC(0.8823%)
since
2025/06/30
24.
Bank of America Corp(0.8487%)
since
2025/06/30
25.
Vanguard Value Index Inv(0.7973%)
since
2025/07/31
26.
Goldman Sachs Group Inc(0.7527%)
since
2025/06/30
27.
Capital Group Wash Mutual Invtrs Comp(0.7182%)
since
2025/06/30
28.
American Funds Washington Mutual A(0.7182%)
since
2025/06/30
29.
Generation Investment Management LLP(0.6935%)
since
2025/06/30
30.
Vanguard Health Care Inv(0.678%)
since
2025/06/30
31.
Parnassus Core Equity Investor(0.6499%)
since
2025/07/31
32.
T. Rowe Price Capital Appreciation(0.6498%)
since
2025/07/31
33.
The Health Care Select Sector SPDR® ETF(0.6074%)
since
2025/08/31
34.
Vanguard Institutional Index I(0.5378%)
since
2025/07/31
35.
Vanguard Dividend Appreciation ETF(0.4801%)
since
2025/07/31
36.
State St S&P 500® Indx SL Cl III(0.4748%)
since
2025/08/31
37.
Capital Group Investment Co of Amer Comp(0.3733%)
since
2025/06/30
38.
American Funds Invmt Co of Amer A(0.3733%)
since
2025/06/30
39.
Six Circles U.S. Unconstrained Equity(0.3449%)
since
2025/03/31
40.
Vanguard Institutional 500 Index Trust(0.3397%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.